The FDA approves the first clinical trial using human embryonic stem cells, which now appear safe enough to use on humans. Ushering in a new era in medicine, the U.S. Food and Drug Administration said Friday that it had cleared the way for the world's first clinical trial of a therapy derived from human embryonic stem cells.